Concepedia

Yoshimichi Shoji

YS

Statistics

Publications

6

Citations

119

H-Index

6

Active since

2004

Affiliations

Kyoto Pharmaceutical Industries (Japan)(Current)

Yoshimichi Shoji is an author at Kyoto Pharmaceutical Industries (Japan) specializing in organic chemistry, chemistry, and medicine.

Top concepts

Publications per year

2004–2018

6

Publications

6

Novel Indoline-Based Acyl-CoA:Cholesterol Acyltransferase Inhibitor with Antiperoxidative Activity: Improvement of Physicochemical Properties and Biological Activities by Introduction of Carboxylic Acid

Kenji Takahashi, Masayasu Kasai, Masaru Ohta et al. · Journal of Medicinal Chemistry · 2008 · 27 citations · Full text

, , +9

Regioselective synthesis of 1-arylindazoles via N-arylation of 3-trimethylsilylindazoles

Yoshiyuki Hari, Yoshimichi Shoji, Toyohiko Aoyama · Tetrahedron Letters · 2005 · 25 citations

, , +2

Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and leptin signaling in mice

Yuma Ito, Masaki Fukui, Mamoru Kanda et al. · Journal of Pharmacological Sciences · 2018 · 21 citations · Full text

Facile synthesis of 3-trimethylsilylindazoles by [3+2]cycloaddition reaction of lithium trimethylsilyldiazomethane with benzynes

Yoshimichi Shoji, Yoshiyuki Hari, Toyohiko Aoyama · Tetrahedron Letters · 2004 · 20 citations

, , +4

Novel Acyl-CoA: Cholesterol Acyltransferase Inhibitor: Indoline-Based Sulfamide Derivatives with Low Lipophilicity and Protein Binding Ratio

Kenji Takahashi, Masaru Ohta, Yoshimichi Shoji et al. · Chemical and Pharmaceutical Bulletin · 2010 · 15 citations · Full text

1–5 of 6